Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Amgen's (NASDAQ:AMGN) Drug Pipeline Matters for the Company's Next Chapter

Amgen's (NASDAQ:AMGN) next chapter will be written by its pipeline, and one experimental medicine in particular has captured investors' attention: a monthly obesity injection that could let the company compete in one of the fastest-growing markets in healthcare. ForNasdaq100 investors, Amgen is a reminder …

Nitish Kishor | 16 September 2026

Cogent Communications (NASDAQ: CCOI) VP Retains 36,200 Shares After September 15 Sale

Cogent Communications Holdings, Inc. (NASDAQ: CCOI) saw VP of Network Strategy Henry W. Kilmer sell 2,400 shares at $9.21 each on September 15, 2026.

Vinay Lochav | 16 September 2026

CalciMedica, Niagen Bioscience, Anavex, Akebia and Upstream Bio Chart Divergent Paths in Biotech

● CalciMedica completed a one-for-fiveReverse Stock Spliteffective 31 August 2026 while reporting FDA alignment on a Phase 2b Auxora trial design and a roughly $49 million private placement.

Nitish Kishor | 16 September 2026

CoreWeave (NASDAQ: CRWV) CFO Exercises Options on September 11, Sells Shares September 14

CoreWeave, Inc. (NASDAQ: CRWV) CFO Nitin Agrawal exercised options covering 122,340 shares, leaving him with 254,936 shares after the transaction. The exercise represented about 48.0% of his resulting share holding.

Vinay Lochav | 16 September 2026

Cadrenal, Upexi, PDS Biotechnology, GeoVax and Atossa Navigate Cash Runway and Clinical Resets

● Cadrenal Therapeutics reported about $2.3 million in cash at 31 March 2026 and lined up an up-to-$8.8 million privatePlacementto extend its runway toward 2027.

Nitish Kishor | 16 September 2026

Credo Technology (NASDAQ: CRDO) CTO Sells 27,500 Shares at Up to $163.88

Credo Technology Group Holding Ltd (NASDAQ: CRDO) Chief Technology Officer Cheng Chi Fung sold 27,500 shares. The transactions were completed at prices ranging from $160.99 to $163.88 per share, marking a disclosed change in the executive’s ownership.

Vinay Lochav | 16 September 2026

Alexandria REAL Estate Equities (NYSE: ARE) Executive Retains 39,152 Shares After Stock Sale

ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE: ARE) saw Kristina Fukuzaki-Carlson sell 16,810 shares at $50.51 per share. The transaction took place on 11 September 2026.

Vinay Lochav | 16 September 2026

Alexandria Real Estate Equities Chairman Buys 5,000 Shares (NYSE: ARE)

Alexandria Real Estate Equities, Inc. (NYSE: ARE) saw Executive Chairman Marcus Joel S buy 5,000 shares at $49.68 per share. The purchase was completed on 11 September 2026.

Vinay Lochav | 16 September 2026

Cousins Properties (NYSE: CUZ) Outlines $1.1 billion Liquidity, Sun Belt Office Strategy

COUSINS PROPERTIES INC. (NYSE: CUZ) has $1.1 billion ofLiquidityin an investor presentation for a BofA Securities conference. The presentation is scheduled for a conference in New York. The materials describe a Sun Belt and Class A office portfolio with a 2014 average year built. …

Vinay Lochav | 16 September 2026

Fortress Credit Realty Income Trust Adds Former Irvine President to Board

Fortress Credit Realty Income Trust appointed Charles H. Fedalen Jr. as a trustee effective September 15, 2026, replacing James B. Perry. Perry resigned from the board, and the trust said the departure was not caused by disagreement over its operations, policies or practices.

Vinay Lochav | 16 September 2026
Support

Hi! How can we help you today?

Loading…